Your session is about to expire
← Back to Search
ON101 Cream for Foot Ulcer
Study Summary
This trial is testing whether a new treatment can help people with open wounds heal. The study will last 20 weeks, and the primary measure of success is whether the wound has completely closed.
- Chronic Diabetic Foot Ulcers
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 3 trial • 236 Patients • NCT01898923Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does your research team plan to test the effects of this medication on people over the age of 55?
"The age range for patients that are being recruited for this clinical trial are those between 18 and 80 years old."
How many different research facilities are running this trial?
"28 hospitals are running this trial currently. They are situated in cities such as McAllen, Carlsbad, and Dallas. You can limit travel if you select a location close to you."
Could I potentially join this clinical research?
"This medical study is looking for 208 participants that have diabetic foot. The study has the following requirements: The subject must be aged 18 to 80 years (inclusive) with Type 1 or Type 2 diabetes undergoing therapy for glycemic control using available diabetes drugs including insulin., The subject has a glycosylated hemoglobin, HbA1c ≦ 12%., A full-thickness ulcer of UTWCS Grade I-A or II-A, Ulcer size (area) is > 2 cm2 and ≤ 20 cm2 (post-debridement at time of randomization), There is a"
Has ON101 Cream been cleared by the FDA?
"There is available data that both supports the efficacy of ON101 Cream and multiple rounds of data collected affirms its safety; as such, we have given it a score of 3."
How many individuals are providing data for this scientific investigation?
"That is correct. Based on the information available on clinicaltrials.gov, this research is still looking for test subjects. The trial was first advertised on 8/10/2021, with the most recent update on 7/15/2022. They are looking for a total of 208 individuals from 28 different locations."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger